{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T08:26:09Z","timestamp":1766305569133,"version":"3.41.2"},"reference-count":43,"publisher":"Sociedade Brasileira de Cardiologia","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,14]]},"DOI":"10.36660\/abc.20230174","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T15:53:15Z","timestamp":1700149995000},"source":"Crossref","is-referenced-by-count":6,"title":["Desafios e Aplica\u00e7\u00f5es dos Testes Gen\u00e9ticos na Cardiomiopatia Dilatada: Gen\u00f3tipo, Fen\u00f3tipo e Implica\u00e7\u00f5es Cl\u00ednicas"],"prefix":"10.36660","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8727-0940","authenticated-orcid":false,"given":"Silas Ramos","family":"Furquim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Linnenkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1061-8982","authenticated-orcid":false,"given":"Nat\u00e1lia Quintella Sangiorgi","family":"Olivetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Rabioglio","family":"Giugni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layara Fernanda Vicente Pereira","family":"Lipari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2612-8040","authenticated-orcid":false,"given":"Fernanda Almeida","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Eduardo","family":"Krieger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22636","reference":[{"issue":"2","key":"key20231116105314_B1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the Cardiomyopathies: A Position Statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","unstructured":". Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the Cardiomyopathies: A Position Statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29(2):270-6. doi: 10.1093\/eurheartj\/ehm342.","journal-title":"Eur Heart J"},{"issue":"23","key":"key20231116105314_B2","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a Revised Definition of Dilated Cardiomyopathy, Hypokinetic Non-Dilated Cardiomyopathy, and its Implications for Clinical Practice: A Position Statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"37","author":"Pinto","year":"2016","unstructured":". Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, B\u00f6hm M, et al. Proposal for a Revised Definition of Dilated Cardiomyopathy, Hypokinetic Non-Dilated Cardiomyopathy, and its Implications for Clinical Practice: A Position Statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2016;37(23):1850-8. doi: 10.1093\/eurheartj\/ehv727.","journal-title":"Eur Heart J"},{"issue":"18","key":"key20231116105314_B3","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","unstructured":". Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895-e1032. doi: 10.1161\/CIR.0000000000001063.","journal-title":"Circulation"},{"issue":"36","key":"key20231116105314_B4","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure","volume":"42","author":"McDonagh","year":"2021","unstructured":". McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. Eur Heart J. 2021;42(36):3599-726. doi: 10.1093\/eurheartj\/ehab368.","journal-title":"Eur Heart J"},{"issue":"2","key":"key20231116105314_B5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/heartjnl-2020-316658","article-title":"Considering Complexity in the Genetic Evaluation of Dilated Cardiomyopathy","volume":"107","author":"Jordan","year":"2021","unstructured":". Jordan E, Hershberger RE. Considering Complexity in the Genetic Evaluation of Dilated Cardiomyopathy. Heart. 2021;107(2):106-12. doi: 10.1136\/heartjnl-2020-316658.","journal-title":"Heart"},{"issue":"10","key":"key20231116105314_B6","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.healun.2019.08.004","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-Sixth Adult Heart Transplantation Report - 2019; Focus Theme: Donor and Recipient Size Match","volume":"38","author":"Khush","year":"2019","unstructured":". Khush KK, Cherikh WS, Chambers DC, Harhay MO, Hayes D Jr, Hsich E, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-Sixth Adult Heart Transplantation Report - 2019; Focus Theme: Donor and Recipient Size Match. J Heart Lung Transplant. 2019;38(10):1056-66. doi: 10.1016\/j.healun.2019.08.004.","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"key20231116105314_B7","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s10741-021-10139-0","article-title":"Dilated Cardiomyopathy in the Era of Precision Medicine: Latest Concepts and Developments","volume":"27","author":"Orphanou","year":"2022","unstructured":". Orphanou N, Papatheodorou E, Anastasakis A. Dilated Cardiomyopathy in the Era of Precision Medicine: Latest Concepts and Developments. Heart Fail Rev. 2022;27(4):1173-91. doi: 10.1007\/s10741-021-10139-0.","journal-title":"Heart Fail Rev"},{"issue":"18","key":"key20231116105314_B8","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/eurheartj\/ehu301","article-title":"Atlas of the Clinical Genetics of Human Dilated Cardiomyopathy","volume":"36","author":"Haas","year":"2015","unstructured":". Haas J, Frese KS, Peil B, Kloos W, Keller A, Nietsch R, et al. Atlas of the Clinical Genetics of Human Dilated Cardiomyopathy. Eur Heart J. 2015;36(18):1123-35a. doi: 10.1093\/eurheartj\/ehu301.","journal-title":"Eur Heart J"},{"issue":"5","key":"key20231116105314_B9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41569-019-0284-0","article-title":"Genetics of Dilated Cardiomyopathy: Practical Implications for Heart Failure Management","volume":"17","author":"Rosenbaum","year":"2020","unstructured":". Rosenbaum AN, Agre KE, Pereira NL. Genetics of Dilated Cardiomyopathy: Practical Implications for Heart Failure Management. Nat Rev Cardiol. 2020;17(5):286-97. doi: 10.1038\/s41569-019-0284-0.","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"key20231116105314_B10","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","article-title":"Dilated Cardiomyopathy: Genetic Determinants and Mechanisms","volume":"121","author":"McNally","year":"2017","unstructured":". McNally EM, Mestroni L. Dilated Cardiomyopathy: Genetic Determinants and Mechanisms. Circ Res. 2017;121(7):731-48. doi: 10.1161\/CIRCRESAHA.116.309396.","journal-title":"Circ Res"},{"issue":"6","key":"key20231116105314_B11","first-page":"1174","article-title":"Emerging Topics Update of the Brazilian Heart Failure Guideline - 2021","volume":"116","author":"Marcondes-Braga","year":"2021","unstructured":". Marcondes-Braga FG, Moura LAZ, Issa VS, Vieira JL, Rohde LE, Sim\u00f5es MV, et al. Emerging Topics Update of the Brazilian Heart Failure Guideline - 2021. Arq Bras Cardiol. 2021;116(6):1174-212. doi: 10.36660\/abc.20210367.","journal-title":"Arq Bras Cardiol"},{"issue":"3","key":"key20231116105314_B12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.36660\/abc.20210718","article-title":"Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis - 2021","volume":"117","author":"Sim\u00f5es","year":"2021","unstructured":". Sim\u00f5es MV, Fernandes F, Marcondes-Braga FG, Scheinberg P, Correia EB, Rohde LEP, et al. Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis - 2021. Arq Bras Cardiol. 2021;117(3):561-98. doi: 10.36660\/abc.20210718.","journal-title":"Arq Bras Cardiol"},{"issue":"13","key":"key20231116105314_B13","first-page":"e272","article-title":"2017 AHA\/ACC\/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"138","author":"Al-Khatib","year":"2018","unstructured":". Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA\/ACC\/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018;138(13):e272-e391. doi: 10.1161\/CIR.0000000000000549.","journal-title":"Circulation"},{"issue":"5","key":"key20231116105314_B14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cardfail.2018.03.004","article-title":"Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline","volume":"24","author":"Hershberger","year":"2018","unstructured":". Hershberger RE, Givertz MM, Ho CY, Judge DP, Kantor PF, McBride KL, et al. Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline. J Card Fail. 2018;24(5):281-302. doi: 10.1016\/j.cardfail.2018.03.004.","journal-title":"J Card Fail"},{"issue":"7","key":"key20231116105314_B15","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.hrthm.2022.03.1225","article-title":"European Heart Rhythm Association (EHRA)\/Heart Rhythm Society (HRS)\/Asia Pacific Heart Rhythm Society (APHRS)\/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Genetic Testing for Cardiac Diseases","volume":"19","author":"Wilde","year":"2022","unstructured":". Wilde AAM, Semsarian C, M\u00e1rquez MF, Sepehri Shamloo A, Ackerman MJ, Ashley EA, et al. European Heart Rhythm Association (EHRA)\/Heart Rhythm Society (HRS)\/Asia Pacific Heart Rhythm Society (APHRS)\/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Genetic Testing for Cardiac Diseases. Heart Rhythm. 2022;19(7):e1-e60. doi: 10.1016\/j.hrthm.2022.03.1225.","journal-title":"Heart Rhythm"},{"issue":"1","key":"key20231116105314_B16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ejhg.2015.226","article-title":"Guidelines for Diagnostic Next-Generation Sequencing","volume":"24","author":"Matthijs","year":"2016","unstructured":". Matthijs G, Souche E, Alders M, Corveleyn A, Eck S, Feenstra I, et al. Guidelines for Diagnostic Next-Generation Sequencing. Eur J Hum Genet. 2016;24(1):2-5. doi: 10.1038\/ejhg.2015.226.","journal-title":"Eur J Hum Genet"},{"issue":"12","key":"key20231116105314_B17","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jacc.2022.06.040","article-title":"Clinical Risk Score to Predict Pathogenic Genotypes in Patients with Dilated Cardiomyopathy","volume":"80","author":"Escobar-Lopez","year":"2022","unstructured":". Escobar-Lopez L, Ochoa JP, Royuela A, Verdonschot JAJ, Dal Ferro M, Espinosa MA, et al. Clinical Risk Score to Predict Pathogenic Genotypes in Patients with Dilated Cardiomyopathy. J Am Coll Cardiol. 2022;80(12):1115-26. doi: 10.1016\/j.jacc.2022.06.040.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"key20231116105314_B18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","unstructured":". Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-24. doi: 10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"issue":"25","key":"key20231116105314_B19","first-page":"e558","article-title":"2020 AHA\/ACC Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"142","author":"Ommen","year":"2020","unstructured":". Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, et al. 2020 AHA\/ACC Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020;142(25):e558-e631. doi: 10.1161\/CIR.0000000000000937.","journal-title":"Circulation"},{"issue":"10","key":"key20231116105314_B20","doi-asserted-by":"crossref","DOI":"10.1007\/s11886-018-1030-7","article-title":"Genetics of Dilated Cardiomyopathy: Clinical Implications","volume":"20","author":"Paldino","year":"2018","unstructured":". Paldino A, De Angelis G, Merlo M, Gigli M, Dal Ferro M, Severini GM, et al. Genetics of Dilated Cardiomyopathy: Clinical Implications. Curr Cardiol Rep. 2018;20(10):83. doi: 10.1007\/s11886-018-1030-7.","journal-title":"Curr Cardiol Rep"},{"issue":"6","key":"key20231116105314_B21","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ahj.2011.07.028","article-title":"Mutations in the Human Phospholamban Gene in Patients with Heart Failure","volume":"162","author":"Medeiros","year":"2011","unstructured":". Medeiros A, Biagi DG, Sobreira TJ, Oliveira PS, Negr\u00e3o CE, Mansur AJ, et al. Mutations in the Human Phospholamban Gene in Patients with Heart Failure. Am Heart J. 2011;162(6):1088-95.e1. doi: 10.1016\/j.ahj.2011.07.028.","journal-title":"Am Heart J"},{"issue":"7","key":"key20231116105314_B22","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJMoa1110186","article-title":"Truncations of Titin Causing Dilated Cardiomyopathy","volume":"366","author":"Herman","year":"2012","unstructured":". Herman DS, Lam L, Taylor MR, Wang L, Teekakirikul P, Christodoulou D, et al. Truncations of Titin Causing Dilated Cardiomyopathy. N Engl J Med. 2012;366(7):619-28. doi: 10.1056\/NEJMoa1110186.","journal-title":"N Engl J Med"},{"issue":"23","key":"key20231116105314_B23","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200012073432304","article-title":"Mutations in Sarcomere Protein Genes as a Cause of Dilated Cardiomyopathy","volume":"343","author":"Kamisago","year":"2000","unstructured":". Kamisago M, Sharma SD, De Palma SR, Solomon S, Sharma P, McDonough B, et al. Mutations in Sarcomere Protein Genes as a Cause of Dilated Cardiomyopathy. N Engl J Med. 2000;343(23):1688-96. doi: 10.1056\/NEJM200012073432304.","journal-title":"N Engl J Med"},{"issue":"8","key":"key20231116105314_B24","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/gim.2013.204","article-title":"The Landscape of Genetic Variation in Dilated Cardiomyopathy as Surveyed by Clinical DNA Sequencing","volume":"16","author":"Pugh","year":"2014","unstructured":". Pugh TJ, Kelly MA, Gowrisankar S, Hynes E, Seidman MA, Baxter SM, et al. The Landscape of Genetic Variation in Dilated Cardiomyopathy as Surveyed by Clinical DNA Sequencing. Genet Med. 2014;16(8):601-8. doi: 10.1038\/gim.2013.204.","journal-title":"Genet Med"},{"issue":"6","key":"key20231116105314_B25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.117.002004","article-title":"Lamin A\/C Cardiomyopathy: Cutting Edge to Personalized Medicine","volume":"10","author":"Sinagra","year":"2017","unstructured":". Sinagra G, Dal Ferro M, Merlo M. Lamin A\/C Cardiomyopathy: Cutting Edge to Personalized Medicine. Circ Cardiovasc Genet. 2017;10(6):e002004. doi: 10.1161\/CIRCGENETICS.117.002004.","journal-title":"Circ Cardiovasc Genet"},{"key":"key20231116105314_B26","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.823717","article-title":"Effect of Occurrence of Lamin A\/C (LMNA) Genetic Variants in a Cohort of 101 Consecutive Apparent \u201cLone AF\u201d Patients: Results and Insights","volume":"9","author":"Pessente","year":"2022","unstructured":". Pessente GD, Sacilotto L, Calil ZO, Olivetti NQS, Wulkan F, Oliveira TGM, et al. Effect of Occurrence of Lamin A\/C (LMNA) Genetic Variants in a Cohort of 101 Consecutive Apparent \u201cLone AF\u201d Patients: Results and Insights. Front Cardiovasc Med. 2022;9:823717. doi: 10.3389\/fcvm.2022.823717.","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"key20231116105314_B27","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/eurheartj\/ehr260","article-title":"Genetics of Inherited Cardiomyopathy","volume":"33","author":"Jacoby","year":"2012","unstructured":". Jacoby D, McKenna WJ. Genetics of Inherited Cardiomyopathy. Eur Heart J. 2012;33(3):296-304. doi: 10.1093\/eurheartj\/ehr260.","journal-title":"Eur Heart J"},{"issue":"21","key":"key20231116105314_B28","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","article-title":"Dystrophin-Deficient Cardiomyopathy","volume":"67","author":"Kamdar","year":"2016","unstructured":". Kamdar F, Garry DJ. Dystrophin-Deficient Cardiomyopathy. J Am Coll Cardiol. 2016;67(21):2533-46. doi: 10.1016\/j.jacc.2016.02.081.","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"key20231116105314_B29","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jacc.2021.08.039","article-title":"Association of Genetic Variants with Outcomes in Patients with Nonischemic Dilated Cardiomyopathy","volume":"78","author":"Escobar-Lopez","year":"2021","unstructured":". Escobar-Lopez L, Ochoa JP, Mirelis JG, Espinosa M\u00c1, Navarro M, Gallego-Delgado M, et al. Association of Genetic Variants with Outcomes in Patients with Nonischemic Dilated Cardiomyopathy. J Am Coll Cardiol. 2021;78(17):1682-99. doi: 10.1016\/j.jacc.2021.08.039.","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"key20231116105314_B30","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","article-title":"Truncating FLNC Mutations Are Associated with High-Risk Dilated and Arrhythmogenic Cardiomyopathies","volume":"68","author":"Ortiz-Genga","year":"2016","unstructured":". Ortiz-Genga MF, Cuenca S, Dal Ferro M, Zorio E, Salgado-Aranda R, Climent V, et al. Truncating FLNC Mutations Are Associated with High-Risk Dilated and Arrhythmogenic Cardiomyopathies. J Am Coll Cardiol. 2016;68(22):2440-51. doi: 10.1016\/j.jacc.2016.09.927.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"key20231116105314_B31","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jchf.2019.06.004","article-title":"Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction","volume":"7","author":"Aimo","year":"2019","unstructured":". Aimo A, Gaggin HK, Barison A, Emdin M, Januzzi JL Jr. Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction. JACC Heart Fail. 2019;7(9):782-94. doi: 10.1016\/j.jchf.2019.06.004.","journal-title":"JACC Heart Fail"},{"issue":"9","key":"key20231116105314_B32","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.healun.2022.03.020","article-title":"Diagnostic Yield of Genetic Testing in Heart Transplant Recipients with Prior Cardiomyopathy","volume":"41","author":"Boen","year":"2022","unstructured":". Boen HM, Loeys BL, Alaerts M, Saenen JB, Goovaerts I, Van Laer L, et al. Diagnostic Yield of Genetic Testing in Heart Transplant Recipients with Prior Cardiomyopathy. J Heart Lung Transplant. 2022;41(9):1218-27. doi: 10.1016\/j.healun.2022.03.020.","journal-title":"J Heart Lung Transplant"},{"issue":"22","key":"key20231116105314_B33","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/eurheartj\/ehq271","article-title":"Genetic Counselling and Testing in Cardiomyopathies: A Position Statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"31","author":"Charron","year":"2010","unstructured":". Charron P, Arad M, Arbustini E, Basso C, Bilinska Z, Elliott P, et al. Genetic Counselling and Testing in Cardiomyopathies: A Position Statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2010;31(22):2715-26. doi: 10.1093\/eurheartj\/ehq271.","journal-title":"Eur Heart J"},{"issue":"19","key":"key20231116105314_B34","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1093\/hmg\/dds265","article-title":"Abnormal p38\u03b1 Mitogen-Activated Protein Kinase Signaling in Dilated Cardiomyopathy Caused by Lamin A\/C Gene Mutation","volume":"21","author":"Muchir","year":"2012","unstructured":". Muchir A, Wu W, Choi JC, Iwata S, Morrow J, Homma S,  et al. Abnormal p38\u03b1 Mitogen-Activated Protein Kinase Signaling in Dilated Cardiomyopathy Caused by Lamin A\/C Gene Mutation. Hum Mol Genet. 2012;21(19):4325-33. doi: 10.1093\/hmg\/dds265.","journal-title":"Hum Mol Genet"},{"issue":"23","key":"key20231116105314_B35","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/CIRCULATIONAHA.117.032273","article-title":"Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR\/Cas9 and Human-Induced Pluripotent Stem Cells","volume":"138","author":"Ma","year":"2018","unstructured":". Ma N, Zhang JZ, Itzhaki I, Zhang SL, Chen H, Haddad F, et al. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR\/Cas9 and Human-Induced Pluripotent Stem Cells. Circulation. 2018;138(23):2666-81. doi: 10.1161\/CIRCULATIONAHA.117.032273.","journal-title":"Circulation"},{"issue":"11","key":"key20231116105314_B36","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy","volume":"16","author":"Towbin","year":"2019","unstructured":". Towbin JA, McKenna WJ, Abrams DJ, Ackerman MJ, Calkins H, Darrieux FCC, et al. 2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy. Heart Rhythm. 2019;16(11):e301-e372. doi: 10.1016\/j.hrthm.2019.05.007.","journal-title":"Heart Rhythm"},{"issue":"7","key":"key20231116105314_B37","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1089\/gtmb.2011.0286","article-title":"The Challenges of Incorporating Genetic Testing in the Unified National Health System in Brazil","volume":"16","author":"Melo","year":"2012","unstructured":". Melo DG, Sequeiros J. The Challenges of Incorporating Genetic Testing in the Unified National Health System in Brazil. Genet Test Mol Biomarkers. 2012;16(7):651-5. doi: 10.1089\/gtmb.2011.0286.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"1","key":"key20231116105314_B38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/nyas.12614","article-title":"Making Personalized Medicine More Affordable","volume":"1346","author":"Aronson","year":"2015","unstructured":". Aronson N. Making Personalized Medicine More Affordable. Ann NY Acad Sci. 2015;1346(1):81-9. doi: 10.1111\/nyas.12614.","journal-title":"Ann NY Acad Sci"},{"key":"key20231116105314_B39","author":"Rede Nacional de Gen\u00f4mica Cardiovascular","year":"2023","unstructured":". Rede Nacional de Gen\u00f4mica Cardiovascular. Cardiovascular R-RNdG [Internet]. S\u00e3o Paulo: Renomica; 2023 [cited 2023 Oct 5]. Available from: https:\/\/www.renomica.org.br\/.","journal-title":"Cardiovascular R-RNdG"},{"key":"key20231116105314_B40","author":"Centro de Medicina de Precis\u00e3o em Cardiologia","year":"2023","unstructured":". Centro de Medicina de Precis\u00e3o em Cardiologia. Cardiologia C-CdMdPe [Internet]. S\u00e3o Paulo: CardioGen; 2023 [cited 2023 Oct 5]. Available from: https:\/\/cardiogen.incor.usp.br\/.","journal-title":"Cardiologia C-CdMdPe"},{"key":"key20231116105314_B41","author":"Brasil","year":"2023","unstructured":". Brasil. Minist\u00e9rio da Sa\u00fade. Projeto Genomas Brasil [Internet]. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade; 2023 [cited 2023 Oct 5]. Available from: https:\/\/www.gov.br\/saude\/pt-br\/composicao\/sectics\/decit\/genomas-brasil.","journal-title":"Projeto Genomas Brasil"},{"key":"key20231116105314_B42","author":"A Benefic\u00eancia Portuguesa de S\u00e3o Paulo","year":"2023","unstructured":". A Benefic\u00eancia Portuguesa de S\u00e3o Paulo. Projeto Mapa Genoma Brasil: Medicina de Precis\u00e3o em Oncologia e Cardiologia no SUS [Internet]. S\u00e3o Paulo: A Benefic\u00eancia Portuguesa de S\u00e3o Paulo; 2023 [cited 2023 Oct 5]. Available from: https:\/\/www.bp.org.br\/institucional\/impacto-social\/projetos-proadi-sus\/projeto-mapa-genoma-brasil.","journal-title":"Projeto Mapa Genoma Brasil: Medicina de Precis\u00e3o em Oncologia e Cardiologia no SUS"},{"key":"key20231116105314_B43","volume-title":"Gen\u00e9tica na Pr\u00e1tica Pedi\u00e1trica","author":"Kim","year":"2019","unstructured":". Kim CA, Albano LMA, Bertola DR, editors. Gen\u00e9tica na Pr\u00e1tica Pedi\u00e1trica. 2nd ed. Barueri: Manole; 2019.","edition":"2nd"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/abccardiol.org\/article\/desafios-e-aplicacoes-dos-testes-geneticos-na-cardiomiopatia-dilatada-genotipo-fenotipo-e-implicacoes-clinicas\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:14:31Z","timestamp":1747401271000},"score":1,"resource":{"primary":{"URL":"https:\/\/abccardiol.org\/article\/desafios-e-aplicacoes-dos-testes-geneticos-na-cardiomiopatia-dilatada-genotipo-fenotipo-e-implicacoes-clinicas\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,11,14]]}},"alternative-id":["10.36660\/abc.20230174"],"URL":"https:\/\/doi.org\/10.36660\/abc.20230174","relation":{},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"type":"print","value":"0066-782X"},{"type":"electronic","value":"1678-4170"}],"subject":[],"published":{"date-parts":[[2023,10]]},"article-number":"e20230174"}}